These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27747393)

  • 21. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
    Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners.
    Read J; Jones R; Owen G; Leavitt BR; Coleman A; Roos RA; Dumas EM; Durr A; Justo D; Say M; Stout JC; Tabrizi SJ; Craufurd D;
    J Huntingtons Dis; 2013; 2(2):159-75. PubMed ID: 25063513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unawareness of motor phenoconversion in Huntington disease.
    McCusker EA; Gunn DG; Epping EA; Loy CT; Radford K; Griffith J; Mills JA; Long JD; Paulsen JS;
    Neurology; 2013 Sep; 81(13):1141-7. PubMed ID: 23966256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
    Winder JY; Achterberg WP; Gardiner SL; Roos RAC
    Eur J Neurol; 2019 May; 26(5):780-785. PubMed ID: 30576046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.
    Paganini M; Biggeri A; Romoli AM; Mechi C; Ghelli E; Berti V; Pradella S; Bucciantini S; Catelan D; Saccardi R; Lombardini L; Mascalchi M; Massacesi L; Porfirio B; Di Lorenzo N; Vannelli GB; Gallina P
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):974-81. PubMed ID: 24347577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a community-based exercise program for people diagnosed and at-risk for Huntington's disease: A clinical report.
    Clark D; Danzl MM; Ulanowski E
    Physiother Theory Pract; 2016; 32(3):232-9. PubMed ID: 27046737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of virtual visits in Huntington disease.
    Bull MT; Darwin K; Venkataraman V; Wagner J; Beck CA; Dorsey ER; Biglan KM
    J Huntingtons Dis; 2014; 3(2):189-95. PubMed ID: 25062861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in Huntington's disease: Which factors matter most?
    Ho AK; Gilbert AS; Mason SL; Goodman AO; Barker RA
    Mov Disord; 2009 Mar; 24(4):574-8. PubMed ID: 19097181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of fitness to drive in Huntington disease.
    Devos H; Nieuwboer A; Tant M; De Weerdt W; Vandenberghe W
    Neurology; 2012 Nov; 79(19):1975-82. PubMed ID: 23100397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
    Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
    Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.